Divi’s Laboratories reported a strong revenue growth of 17% to ₹2,860 crore and a net profit increase of 35% to ₹689 crore for Q2. The company is expanding its peptide offerings and executing capital expenditure programs, despite facing pricing pressures in its generic business.
Divi’s Laboratories reported a strong revenue growth of 17% to ₹2,860 crore and a net profit increase of 35% to ₹689 crore for Q2. The company is expanding its peptide offerings and executing capital expenditure programs, despite facing pricing pressures in its generic business. by Soban News (international And National News)
